Compounds > irinotecan
Page last updated: 2024-08-24

irinotecan and titanium

irinotecan has been researched along with titanium in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Kinoshita, H; Kitaura, T; Nakae, S; Onoyama, H; Sainoh, K; Saitoh, Y; Shiroiwa, H; Sugihara, S; Takahashi, T; Takao, S; Toyota, J; Urakawa, T; Yamamoto, M1
Aizawa, M; Ishibashi, K; Itagaki, H; Katsube, T; Kobayashi, R; Naritaka, Y; Ogawa, K; Yokomizo, H; Yoshimatsu, K1
Goto, S; Kamigaki, T; Saito, M; Yano, K1
Chen, Y; Gong, S; Li, N; Pan, W; Tang, B; Wang, J; Yu, L1
Ao, Y; Liu, Y; Tong, L; Yu, T; Zhang, G; Zhang, H1

Other Studies

6 other study(ies) available for irinotecan and titanium

ArticleYear
[A patient with peritoneal metastasis from gastric cancer who responded to weekly chemotherapy with paclitaxel on the third line and could take meal].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:8

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Humans; Irinotecan; Male; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Silicates; Stomach Neoplasms; Titanium

2003
[Host immunity in colorectal cancer patients treated with TS-1 plus CPT-11].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:11

    Topics: Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Colorectal Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Irinotecan; Silicates; Titanium

2005
A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA).
    Anticancer research, 2013, Volume: 33, Issue:7

    Topics: Adenocarcinoma, Scirrhous; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Signet Ring Cell; Cisplatin; Combined Modality Therapy; Dichloroacetic Acid; Docetaxel; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hyperthermia, Induced; Irinotecan; Ovarian Neoplasms; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Photosensitizing Agents; Prognosis; Silicates; Stomach Neoplasms; Taxoids; Tegafur; Titanium

2013
Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Pancreatic Adenocarcinoma.
    Annals of the Academy of Medicine, Singapore, 2015, Volume: 44, Issue:10

    Topics: Adenocarcinoma; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Carcinoma, Pancreatic Ductal; Cetuximab; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Deoxycytidine; Fluorouracil; Gemcitabine; Humans; Irinotecan; Leucovorin; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms; Silicates; Singapore; Titanium

2015
A nuclear-targeted titanium dioxide radiosensitizer for cell cycle regulation and enhanced radiotherapy.
    Chemical communications (Cambridge, England), 2019, Jul-18, Volume: 55, Issue:56

    Topics: Cell Cycle; Cell Line, Tumor; Cell Nucleus; Humans; Irinotecan; Metal Nanoparticles; Microscopy, Electron, Transmission; Oligopeptides; Radiation-Sensitizing Agents; Radiotherapy; Reactive Oxygen Species; Titanium; Topoisomerase I Inhibitors; X-Rays

2019
NIR triggered PLGA coated Au-TiO
    Drug delivery, 2020, Volume: 27, Issue:1

    Topics: Biocompatible Materials; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Humans; Irinotecan; Metal Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Thyroid Cancer, Papillary; Titanium; Topoisomerase I Inhibitors; Treatment Outcome

2020